99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy. 1982

A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie

One hundred eighty-four 99mTc-labeled macroaggregated albumin (99mTc-MAA) perfusion studies were carried out in 39 patients with histologically proven primary (four) and metastatic (35) hepatic neoplasms. Three different patterns of tumor perfusion were observed: (1) increased central radioactivity (33%); (2) decreased central radioactivity (33%); and (3) mixed and/or diffuse radioactivity (33%). Extrahepatic perfusion as evidenced by radioactive localization in the region of the stomach, pancreas, and small bowel was noted in 51%. Its presence was associated with a higher incidence of gastrointestinal complications (45% vs. 16%). Tumor arteriovenous shunting was demonstrated in 38%, showing localization of radiotracer activity in the lungs, and decreased as tumors decreased in size. The use of 99mTc-MAA infusion studies in intrahepatic arterial chemotherapy offers an excellent evaluation of catheter placement and tumor perfusion, in addition to helping to avoid gastrointestinal complications.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
June 1999, American journal of clinical oncology,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
February 1984, Cancer,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
March 2022, Clinical nuclear medicine,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
August 2013, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
January 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
April 2021, Radiology case reports,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
April 1976, Nuklearmedizin. Nuclear medicine,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
October 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
April 2022, Clinical nuclear medicine,
A G Bledin, and H M Kantarjian, and E E Kim, and S Wallace, and V P Chuang, and Y Z Patt, and T P Haynie
August 1983, JAMA,
Copied contents to your clipboard!